CENCORA INC (COR) Stock Price, Quote, News and Overview
NYSE:COR - New York Stock Exchange, Inc. - US03073E1055 - Common Stock
COR Quote and Key Statistics
CENCORA INC
NYSE:COR (1/21/2025, 8:04:00 PM)
Premarket: 242.18 -2.89 (-1.18%)245.07
+3.02 (+1.25%)
COR Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.51% | ||
| ROA | 2.25% | ||
| ROE | 233.63% | ||
| Debt/Equity | 5.9 |
COR Performance and Technical Analysis
COR Ownership and Analysts
COR Latest News and Analysis
COR March 21st Options Begin Trading
Jim Cramer: Lemonade Is 'Up Too Much,' This Health Care Stock Can Go Lower
JMP Securities analyst Ronald Josey maintained Lemonade with a Market Outperform and raised the price target from $40 to $60.
Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release
COR Makes Bullish Cross Above Critical Moving Average
Cencora Completes Acquisition of Retina Consultants of America
About COR
Company Profile
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania. The firm is focused on improving the lives of people and animals around the world. The company is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Company Info
CENCORA INC
1 West First Avenue
Conshohocken PENNSYLVANIA 80202 US
CEO: Paul E. Szurek
Employees: 44000
Company Website: https://www.cencora.com/
Investor Relations: https://investor.amerisourcebergen.com
Phone: 16107277000
COR Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 20.3 | 74.40B | ||
| CAH | CARDINAL HEALTH INC | 16.78 | 30.94B | ||
| HSIC | HENRY SCHEIN INC | 17.62 | 9.25B | ||
| PDCO | PATTERSON COS INC | 14.6 | 2.73B | ||
| AHCO | ADAPTHEALTH CORP | N/A | 1.41B | ||
| OMI | OWENS & MINOR INC | 8.99 | 1.15B | ||
| AHG | AKSO HEALTH GROUP | N/A | 594.24M | ||
| COSM | COSMOS HEALTH INC | N/A | 21.63M | ||
| VRAX | VIRAX BIOLABS GROUP LTD | N/A | 9.07M | ||
| ATPC | AGAPE ATP CORP | N/A | 5.99M |